VEGFA and urinary bladder neoplasm: The most well-studied and clinically relevant angiogenic mediator in both invasive and non-invasive BC is vascular endothelial growth factor (VEGF), with a high expression being associated with deeper, high-grade, aggressive tumors of the bladder [5] and elevated urinary VEGF levels predicting recurrence of superficial BC [6].